Answers are grounded in this paper and cite their sources.
Biallelic loss-of-function variants in PCDHGC4 cause a rare autosomal recessive neurodevelopmental disorder characterized by developmental delay or intellectual disability, severe speech impairment, gait abnormalities, and variably microcephaly, seizures, and joint anomalies. The transcript-level consequence of premature termination variants is important because nonsense-mediated mRNA decay (NMD) may preclude production of a stable truncated protein. We clinically evaluated a 9-year-old Iranian Sistani boy and performed whole-exome sequencing followed by Sanger validation and segregation analysis. Variant nomenclature and exon architecture were verified against the MANE Select transcript NM_018928.3. NMD was assessed using canonical exon-junction-complex rules and the UCSC NMDetective-AI track. The patient had moderate intellectual disability, absent speech, esotropic strabismus, delayed walking, and a persistent wide-based unsteady gait, without seizures, microcephaly, or joint hypermobility at the most recent assessment. Brain MRI showed symmetric peritrigonal white-matter hyperintensities without a major structural anomaly. A novel homozygous NM_018928.3:c.1369 C > T variant was identified in PCDHGC4 ; codon-level validation corrected the protein consequence to NP_061751.1:p.(Gln457Ter). The premature termination codon lies in exon 1 of 4, 1071 nucleotides upstream of the first downstream exon-exon junction and 1219 nucleotides upstream of the final junction. Canonical rules therefore predict NMD sensitivity, whereas NMDetective-AI yielded an intermediate/uncertain score (-0.1644), close to its NMD-evading threshold. This additional family expands the phenotypic and allelic spectrum of PCDHGC4 -related neurodevelopmental disorder. The most defensible current mechanism is loss of function, with NMD predicted by the canonical positional rule but not experimentally confirmed. Patient-derived RNA studies are required to determine NMD efficiency and whether any truncated protein is produced.
No takes yet. Share an insight, caveat, or question.
Khosravi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: